Search results for "312 Clinical medicine"

showing 2 items of 2 documents

A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing live…

2010

Abstract Background The potential anti-cancer effects of mammalian target of rapamycin (mTOR) inhibitors are being intensively studied. To date, however, few randomised clinical trials (RCT) have been performed to demonstrate anti-neoplastic effects in the pure oncology setting, and at present, no oncology endpoint-directed RCT has been reported in the high-malignancy risk population of immunosuppressed transplant recipients. Interestingly, since mTOR inhibitors have both immunosuppressive and anti-cancer effects, they have the potential to simultaneously protect against immunologic graft loss and tumour development. Therefore, we designed a prospective RCT to determine if the mTOR inhibito…

OncologyCancer ResearchTime Factorsmedicine.medical_treatmentMedizinIntracellular Signaling Peptides and Proteins - antagonists & inhibitors metabolismKaplan-Meier Estimate312 Clinical medicineProtein-Serine-Threonine KinaseLiver transplantationTHERAPYStudy ProtocolImmunosuppressive Agentendothelial growth-factor renal-cell carcinoma tumor progression rapamycin cancer cyclosporine efficacy therapy target model0302 clinical medicineRENAL-CELL CARCINOMARisk FactorsRecurrenceSurgical oncologyMedicine and Health SciencesLiver Neoplasms - drug therapy enzymology mortality surgerySirolimuProspective StudiesTUMOR PROGRESSIONTransplantation Homologoueducation.field_of_studyliver transplantationTOR Serine-Threonine KinasesLiver NeoplasmsIntracellular Signaling Peptides and ProteinsImmunosuppressionhepatocellular carcinomalcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensCANCER3. Good healthEuropeMulticenter StudyTreatment OutcomeTARGETsirolimusOncologyLiver Neoplasm030220 oncology & carcinogenesisHepatocellular carcinomaRandomized Controlled TrialmTORCarcinoma Hepatocellular - drug therapy enzymology mortality surgery030211 gastroenterology & hepatologyImmunosuppressive AgentsRCTHumanmedicine.drugCanadamedicine.medical_specialtyCarcinoma HepatocellularTime FactoreducationPopulationLiver Transplantation - adverse effects mortalityProtein Serine-Threonine Kinaseslcsh:RC254-282Disease-Free Survival03 medical and health sciencesInternal medicineGeneticsmedicineTransplantation HomologousHumansComparative StudyRapamycinddc:610educationProtein-Serine-Threonine Kinases - antagonists & inhibitors metabolismKaplan-Meiers Estimatebusiness.industryRisk FactorAustraliaImmunosuppressive Agents - therapeutic useSirolimus - therapeutic useEFFICACYHumans; Liver Transplantation; Hepatocellular Carcinoma; Randomized Controlled Trial; RCT; Multicenter Study; Comparative Study; Rapamycin; mTOR; Sirolimusmedicine.diseaseSurgeryMODELTransplantationClinical trialProspective StudieIntracellular Signaling Peptides and ProteinSirolimusENDOTHELIAL GROWTH-FACTORCYCLOSPORINERAPAMYCINbusiness
researchProduct

Auditory and Cognitive Deficits Associated with Acquired Amusia after Stroke: A Magnetoencephalography and Neuropsychological Follow-Up Study

2010

Acquired amusia is a common disorder after damage to the middle cerebral artery (MCA) territory. However, its neurocognitive mechanisms, especially the relative contribution of perceptual and cognitive factors, are still unclear. We studied cognitive and auditory processing in the amusic brain by performing neuropsychological testing as well as magnetoencephalography (MEG) measurements of frequency and duration discrimination using magnetic mismatch negativity (MMNm) recordings. Fifty-three patients with a left (n = 24) or right (n = 29) hemisphere MCA stroke (MRI verified) were investigated 1 week, 3 months, and 6 months after the stroke. Amusia was evaluated using the Montreal Battery of …

PITCHMalemagnetoencephalographyMiddle Cerebral ArteryAnatomy and Physiologylcsh:MedicineMismatch negativity312 Clinical medicineNeuropsychological TestsAudiologymagnetic fieldsCardiovascularSocial and Behavioral SciencesBehavioral NeuroscienceLearning and MemoryCognition0302 clinical medicinePsychologyMedicinelcsh:Sciencemagnetoencephalography and neuropsychologicalClinical NeurophysiologyMultidisciplinarymedicine.diagnostic_testBRAIN RESPONSES05 social sciencesStroke RehabilitationCognitive flexibilityNeuropsychologyMagnetoencephalographyElectroencephalographyExperimental Psychologyfollow-up studyMiddle Aged3. Good healthElectrophysiologyStrokeHemorrhagic StrokeClinical PsychologyMemory Short-TermNeurologyMedicineSensory PerceptionFemaleMUSIC PERCEPTION DEFICITSResearch ArticleAdultCORTEXmedicine.medical_specialtyMISMATCH NEGATIVITY MMN515 PsychologyCognitive NeuroscienceCerebrovascular DiseasesNeuroimagingAmusiaAuditory cortex050105 experimental psychologyLateralization of brain functionPerceptual Disorders03 medical and health sciencesNeuropsychologyDiagnostic MedicineSPEECH INTONATIONHumans0501 psychology and cognitive sciencesBiologyMusic TherapyIschemic StrokeAuditory CortexCONGENITAL AMUSIAbusiness.industryMEMORYlcsh:R3112 NeurosciencesMagnetoencephalographymedicine.diseaseAuditory and cognitive deficits6131 Theatre dance music other performing artsNeuroanatomyDISCRIMINATIONBrain Injurieslcsh:QNEURAL-NETWORKSbusinessNeurocognitive030217 neurology & neurosurgeryNeuroscienceFollow-Up Studies
researchProduct